Researchers Are Testing Whether Psilocybin Can Treat Depression in Lung Cancer Patients

Researchers at The Ohio State University Comprehensive Cancer Center and the Center for Psychedelic Drug Research and Education are conducting the first clinical trial to test psilocybin-assisted therapy for depression in people with lung cancer. The trial involves a single dose of psilocybin, with participants completing eight hours of preparatory sessions with two therapists before receiving the dose in a controlled clinical setting. The study is enrolling patients with non-small cell lung cancer, the most prevalent subtype of the disease. Psilocybin-assisted therapy has shown promise in relieving depression in people with cancer, but this is the first study specifically targeting lung cancer patients.

The study is based on the belief that psilocybin may help address the unique psychological challenges faced by lung cancer patients, including anxiety, existential distress, and concerns about their future. Researchers are monitoring whether psilocybin affects inflammation, although this aspect of the research is still in its early stages. The trial is still experimental, and psilocybin-assisted therapy has not been approved for general clinical use. Participants undergo careful screening and receive treatment under close medical supervision. Betty Paschall, a lung cancer patient, reported improvements in her outlook after participating in the trial, indicating potential benefits for patients with advanced lung cancer.

The study reflects a broader effort to address both the psychological and physical burdens of advanced lung cancer. While results from the trial are not yet available, Paschall’s experience is anecdotal and preliminary. The researchers emphasize that the trial is still in its early stages and that further studies may be needed to determine which patient groups are most likely to benefit. The study highlights the growing interest in using psilocybin-assisted therapy to address mental health challenges in cancer care.

AI-generated summary of the original article — see the source for the full story.